AstraZeneca staff detained in China amid claims of illegal drug imports
Shenzhen authorities investigate pharma giant over data collection and liver cancer treatment
![A vial, a syringe and an AstraZeneca logo](/https/www.telegraph.co.uk/content/dam/business/2024/09/05/TELEMMGLPICT000345198083_17255254418170_trans_NvBQzQNjv4BqDAoCN0zt2fIWNcwvVaupU4MgS4Zd_nvCtxOLqYKfDhI.jpeg?imwidth=350)
Shenzhen authorities investigate pharma giant over data collection and liver cancer treatment
NHS warns of backlogs in collecting medicine following chaos on Friday after 8.5m Microsoft devices were impacted
Fear of jabs has companies scrambling to be the first to launch the ‘holy grail’ of obesity drugs
Pharmaceutical giant to trial experimental treatment as demand for obesity remedies surges
Share tip: this pharma giant’s patent may be up but its time in the spotlight is not
Walgreens fails again to secure new owner for pharmacy or list it on the stock market
Income portfolio: this high-quality, competitive company is well placed to overcome risks
Walgreens abandons plans to cash in on pharmacy chain after profit warning
Pharmacists warn that unregulated access and lax online checks encourage dangerous misuse
Zantac debacle is casting a long shadow over Dame Emma Walmsley’s legacy
A new approach to the disease has kickstarted a race to halt its development at source
AstraZeneca and GSK vow to upgrade facilities as part of president’s new programme
Obesity wonder drug costing Americans $6,700 a month, says politician
The jab has been linked to at least 81 fatalities and numerous injuries. How did it work and, if you had it, should you be concerned?
Pharma boss insists she is ‘very well paid’ amid calls for US-style pay packages in London
Retaliation comes amid fears lower pay for UK executives is driving companies to the US
E-therapeutics joins the stampede of biotech companies quitting Aim
Suggestion among an array of green proposals British companies urged to consider
Drug companies could be next in the UK market exodus if the Government doesn’t step in
Obesity drug trial patients lose 13pc of their weight, compared to 6pc with Wegovy
Commercial interests are medicalising the condition, which is part of healthy ageing, says research paper in The Lancet
All-party group believe MHRA were aware of heart and clotting issues in February 2021 but did not highlight the problems for several months
New drug as effective as existing treatments, GSK says, as pharma giants seek alternatives